11 Kidney biopsies in SLE: too few or too many? by Hans-Joachim Anders

Neutrophils and Neutrophil Extracellular Traps Regulate Immune Responses in Health and Disease by Shrikant R. Mulay, Hans-Joachim Anders

Get full text

Toll-like receptors in lupus nephritis by Satish Kumar Devarapu, Hans-Joachim Anders

Get full text

Novel Criteria for When and How to Exit a COVID-19 Pandemic Lockdown by Chenyu Li, Paola Romagnani, Hans-Joachim Anders

Get full text

Extracellular DNA—A Danger Signal Triggering Immunothrombosis by Chongxu Shi, Luying Yang, Attila Braun, Hans-Joachim Anders

Get full text

Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials by Stefanie Steiger, Louisa Ehreiser, Juliane Anders, Hans-Joachim Anders

Get full text

Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis by Tamisa Seeko Bandeira Honda, John Ku, Hans-Joachim Anders

Get full text

Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19 by Bhawna Tomar, Hans-Joachim Anders, Jyaysi Desai, Shrikant R. Mulay

Get full text

p53-Independent Roles of MDM2 in NF-κB Signaling: Implications for Cancer Therapy, Wound Healing, and Autoimmune Diseases by Dana Thomasova, Shrikant R. Mulay, Hauke Bruns, Hans-Joachim Anders

Get full text

Danger Control Programs Cause Tissue Injury and Remodeling by Hans-Joachim Anders, Susanna Müller, Holger Haegele, Jan H. Hagemann

Get full text

1110 Voclosporin is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations by Hans-Joachim Anders, Ray Federico, Simrat Randhawa, Henry Leher, Elmar Orujov

Polyene macrolide antifungal drugs trigger interleukin-1β secretion by activating the NLRP3 inflammasome. by Murthy Narayana Darisipudi, Ramanjaneyulu Allam, Khader Valli Rupanagudi, Hans-Joachim Anders

Get full text

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment by Kyriakos A. Kirou, Maria Dall`Era, Cynthia Aranow, Hans-Joachim Anders

Get full text

“Point of no return” in unilateral renal ischemia reperfusion injury in mice by Alexander Holderied, Franziska Kraft, Julian Aurelio Marschner, Marc Weidenbusch, Hans-Joachim Anders

Get full text

How to use COVID-19 antiviral drugs in patients with chronic kidney disease by Ajinath Kale, Vishwadeep Shelke, Neha Dagar, Hans-Joachim Anders, Anil Bhanudas Gaikwad

Get full text

Voclosporin: Unique Chemistry, Pharmacology and Toxicity Profile, and Possible Options for Implementation into the Management of Lupus Nephritis by Ajinath Kale, Vishwadeep Shelke, Yutian Lei, Anil Bhanudas Gaikwad, Hans-Joachim Anders

Get full text

Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies by Medina Mamtimin, Medina Mamtimin, Akif Pinarci, Chao Han, Chao Han, Attila Braun, Hans-Joachim Anders, Hans-Joachim Anders, Thomas Gudermann, Thomas Gudermann, Elmina Mammadova-Bach, Elmina Mammadova-Bach

Get full text

Inflammatory Networks in Renal Cell Carcinoma by Linus Kruk, Medina Mamtimin, Attila Braun, Hans-Joachim Anders, Joachim Andrassy, Thomas Gudermann, Elmina Mammadova-Bach

Get full text

Editorial: Nano- and Microparticle-Induced Cell Death, Inflammation and Immune Responses by Shrikant R. Mulay, Shrikant R. Mulay, Martin Herrmann, Rostyslav Bilyy, Rostyslav Bilyy, Alexander Gabibov, Hans-Joachim Anders

Get full text

Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies by Anna Kletzmayr, Shrikant R. Mulay, Manga Motrapu, Zhi Luo, Hans‐Joachim Anders, Mattias E. Ivarsson, Jean‐Christophe Leroux

Get full text